Variant Bio - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeVariant Bio
Variant Bio logo

Variant Bio

0 followers

About Variant Bio

Variant Bio leverages human genetic diversity to develop life-saving therapies, focusing on understanding how genes influence health traits. The company integrates genetics, drug discovery, molecular biology, anthropology, and ethics to advance genomic drug discovery and partnerships worldwide. Based in Seattle, Variant Bio highlights ethical engagement and benefit-sharing with partner communities as a core principle of its research model. Its work aims to transform drug development by using human genetics to identify molecular targets and improve clinical outcomes.

Recent News

Recent Deals

Key Facts

HQ Location

Seattle, United States

Founded

2018

Employees

11 - 50

Status

Investor

Investor Type

Venture Investor

Website

https://variantbio.com